Journal for ImmunoTherapy of Cancer Q1 Unclaimed
Journal for ImmunoTherapy of Cancer is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 80. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1694 €. The scope of the journal is focused on tumour immunology, cancer immunotherapy, immunotherapy biomarkers. It has an SJR impact factor of 3,45 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,45.
Journal for ImmunoTherapy of Cancer focuses its scope in these topics and keywords: immunotherapy, response, cancer, cell, tumor, carcinoma, annual, society, therapy, patient, ...
Type of Copyright: CC BY
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -